Critically Appraised Topic Flashcards

1
Q

What is selection bias?

A

= error is assigning indidivuals to groups leading to differences that may influence the outcome

The subjects are not representative of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Selection bias: what is sampling bias?

A

= selected subjects are not representative of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Selection bias: what is volunteer bias?

A

= the volunteer subjects are not representative of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Selection bias: what is non-responder bias?

A

= the respondants (subjects) are not representative of the population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Selection bias may be a particular problem in which type of observation study?

A

= cohort studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a cohort study?

A

= involves finding a sample that do not have the outcome (e.g., lung cancer)

Group them according to exposure

Follow them forward to see who develops the outcome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a case control study?

A

= find a sample that HAS the outcome AND, find a control sample that doesn’t have the outcome

Look to the past to find out who was exposed to the exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is recall bias?

A

= difference in the accuracy of recollection of study participants, possible due to whether they have the outcome of not

(e.g., patient with mesothelioma may try harder to remember exposure to asbestos than a control patient)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

In which type of observational study is recall bias a particular problem?

A

= case-control study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is publication bias?

A

= failure to publish/ include results from valid studies, often because they show a negative or uninteresting result

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In which type of studies may publication bias be a problem? (2)

A
  • meta-analysis
  • systematic reviews

(studies showing negative results may be excluded)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is work-up bias (verification bias)?

A

= this refers to the gold-standard test being preformed more frequently in patients who have already had a positive result from the new test

e.g.,those with a +ve d-dimer may be assessed further using ultrasonography, whereas those with a -ve d-dimer will be assessed with 3-month follow up. Patients who had a DVT, but neg. d-dimer may not have been diagnosed by 3-month follow-up. This risks underestimating the no of false negatives, and thus may overestimate the sensitivity of a new test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is an expectation bias (pygmalion effect)?

And how is it tackled?

A

= observers may subconsciously measure or report data in a way that favours the expected study outcome

= avoided by blinding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What the hawthorne effect?

A

= group changing it’s behaviour due to knowledge that it is being studied

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is procedure bias?

A

= subjects in differed groups receive different treatment, other than just interventions

(e.g., elderly patients could receive human contact along with intervention, whereas control patients get no extra human contact)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is length-time bias?

A

= screening over-represents less-aggressive disease

e.g., aggressive tumours have a shorted asymptomatic (screening) period, so screening is less likely to detect aggressive tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is lead-time bias?

A

= early diagnosis appears to prolong survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is late-look bias?

A

= gathering information at an inappropriate time

e.g., studying a fatal disease many years later when some patients may have died

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Advantages of a cohort study (3)

A
  • best information about causation of disease, as can work out incidence
  • able to examine range of outcomes from a particular exposure
  • good for rare exposures - can select those exposed to certain things
19
Q

Disadvantages of a cohort study? (8)

A
  • long follow-up period, expensive & time consuming
  • bad for rare outcomes - would require enormous sample size
  • bad for long latent periods (have to wait ffor disease to develop)
  • misclassified exposure (lying)
  • different follow up for exposed/ non-exposed
  • outcome assessors not blind to exposre category
  • selection bias - subjects not representative of the population as a whole
  • confounders not recognised/ addressed
20
Q

Advantages of case control studies? (3)

A
  • simple/ easy to consuct, does not require long follow up
  • good for rare outcomes - can select patients with certain disease
  • good for long latent periods - finding patients after disease developed, not waiting after exposure
21
Q

Disadvantages of a case control study? (5)

A
  • bad for rare exposures - would require an enormous sample size
  • controls may not represent the population where the sample is from
  • cases don’t represent full disease spectrum (e.g., fatal vs. non-fatal lung cancers)
  • recall bias - different reporting of exposure drom different groups
  • confounders not recognised/ addressed
22
Q

What is equipoise?

A

= the situation where the researchers have no preference between the 2 interventions being studied in the trial

23
Q

Why is equipoise important?

A

= important as it is unethical to run a trial when you alread known one intervention is inferior, becasue you are exposing those patients to sub-optimal treatment, and perhaps unnecessary risk of harm

24
Q

What kind of bias may incomplete randomisation lead to?

A

= selection buas, where there are significant baseline differnces

25
Q

Ideal method of randomisation?

A

= random computer-generated numbers

26
Q

Is randomisation based on date of presentation, order of presentations, letter of name or DOB adequate methods of randomisation?

Why?

A

= no,

may allow the allocating clinician to predict which group the patient might be in before deciding to recruit them into the study

27
Q

What might you do to improve randomisation?

A

= stratify

28
Q

What is stratified randomisation?

A

= with powerful confounders, patients can be first split, or stratified, into different groups before randomisation so there will be the same number of pateints with and without the confounder in each arm of the trial

29
Q

What is power?

A

= power is equal to the chance of detected a true difference when there really is one

(80-90% is usually an acceptable power value)

30
Q

What is an approximately acceptable power?

A

= 80-90%

31
Q

Why might a trial be underpowered?

A

= not enough participants, therefore th real effect (or lack of effect) of a treatment cannot be established from random variation

32
Q

What kind of error might an unpowered trial lead to?

A

= type II (false negative)

33
Q

What is subversion bias?

A

= refers to the deliberate manipulation of patient recruitment by clinicans in order to influence trial results

(may be done actively, for example shining a light through an envelope to determine allocation group, or subtly, when a clinican decides not to recruit to a trial a patient who they feel might not do well)

34
Q

Benefits of combining data in a meta-analysis? (3)

A
  • increases size of study sample
  • improves precision, and reduces the width of the CIs
  • can demonstrate a significant result when none of the trials could do this individually
35
Q

Meta-analysis: what happens if you combine data that is too heterogenous?

A

= the analysis can provide data that is meaningless or misleading

36
Q

How can you limit confounding in a cohort study? (3)

A
  • restriction
  • matching & stratification
  • multiple cariable regression
37
Q

What is multiple variable regression?

A

= co-efficients are established for the confounder groups. Allows for better adjustment

38
Q

Challenges to measuring exposure in case controls? (3)

A
  • recall bias
  • variable exposure
  • unavailable data
39
Q

Which of the following types of studies provides the best evidence to answer a question on DIAGNOSIS?

  • cross-sectional analytic study
  • cohort study
  • case-control study
  • meta-analysis
  • RCT
  • systematic review
A
  • cross-sectional analytic study
40
Q

Which of the following types of studies provides the best evidence to answer a question on AETIOLOGY? (2)

  • cross-sectional analytic study
  • cohort study
  • case-control study
  • meta-analysis
  • RCT
  • systematic review
A
  • cohort study
  • case-control study
41
Q

Which of the following types of studies provides the best evidence to answer a question on PROGNOSIS?

  • cross-sectional analytic study
  • cohort study
  • case-control study
  • meta-analysis
  • RCT
  • systematic review
A
  • cohort study
42
Q

Which of the following types of studies provides the best evidence to answer a question on TREATMENT? (2)

  • cross-sectional analytic study
  • cohort study
  • case-control study
  • meta-analysis
  • RCT
  • systematic review
A
  • RCT

(systematic review of RCTs)

43
Q

Which of the following types of studies provides the best evidence to answer a question on EVALUATION? (2)

  • cross-sectional analytic study
  • cohort study
  • case-control study
  • meta-analysis
  • RCT
  • systematic review
A
  • systematic review
  • meta-analysis
44
Q

What is treatment fidelity?

A

= how accurately the intervention is reproduced from a protocol or model

45
Q

What is internal validity?

A

= how well study was conducted, taking confounders into acount + removign bias

46
Q
A